ZA905886B - New oral pharmaceutical dosage form improving bioavailability - Google Patents
New oral pharmaceutical dosage form improving bioavailabilityInfo
- Publication number
- ZA905886B ZA905886B ZA905886A ZA905886A ZA905886B ZA 905886 B ZA905886 B ZA 905886B ZA 905886 A ZA905886 A ZA 905886A ZA 905886 A ZA905886 A ZA 905886A ZA 905886 B ZA905886 B ZA 905886B
- Authority
- ZA
- South Africa
- Prior art keywords
- dosage form
- pharmaceutical dosage
- oral pharmaceutical
- new oral
- improving bioavailability
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8910605A FR2650502B1 (fr) | 1989-08-07 | 1989-08-07 | Nouvelle forme galenique orale ameliorant la biodisponibilite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA905886B true ZA905886B (en) | 1991-04-24 |
Family
ID=9384532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA905886A ZA905886B (en) | 1989-08-07 | 1990-07-26 | New oral pharmaceutical dosage form improving bioavailability |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0412877A1 (en, 2012) |
| JP (1) | JPH0377819A (en, 2012) |
| KR (1) | KR910004181A (en, 2012) |
| CN (1) | CN1049455A (en, 2012) |
| AU (1) | AU631235B2 (en, 2012) |
| CA (1) | CA2022447A1 (en, 2012) |
| CS (1) | CS383890A3 (en, 2012) |
| DD (1) | DD297332A5 (en, 2012) |
| DE (1) | DE4023136A1 (en, 2012) |
| FI (1) | FI903885A7 (en, 2012) |
| FR (1) | FR2650502B1 (en, 2012) |
| GB (1) | GB2234898A (en, 2012) |
| HU (1) | HU204997B (en, 2012) |
| IE (1) | IE902629A1 (en, 2012) |
| IL (1) | IL95105A0 (en, 2012) |
| IN (1) | IN170789B (en, 2012) |
| LU (1) | LU87777A1 (en, 2012) |
| MA (1) | MA21923A1 (en, 2012) |
| NO (1) | NO903442L (en, 2012) |
| NZ (1) | NZ234593A (en, 2012) |
| OA (1) | OA09301A (en, 2012) |
| PE (1) | PE491A1 (en, 2012) |
| PT (1) | PT94823A (en, 2012) |
| TN (1) | TNSN90111A1 (en, 2012) |
| ZA (1) | ZA905886B (en, 2012) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07502736A (ja) * | 1992-01-17 | 1995-03-23 | アルファテック−ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 親水性巨大分子からなる骨格を有する作用物質含有固形物およびその調製法 |
| DE4221880A1 (de) * | 1992-07-03 | 1994-01-05 | Alfatec Pharma Gmbh | Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen |
| KR20030089147A (ko) * | 2002-05-16 | 2003-11-21 | 슈라펫 주식회사 | 애완동물용 급수통 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE854414C (de) * | 1949-04-26 | 1952-11-04 | Dieter Dr Med Ellenbeck | Verfahren zur Herstellung von injizierbaren Loesungen von an sich mehr oder weniger schwer loeslichen Arzneimitteln |
| GB715874A (en) * | 1952-10-03 | 1954-09-22 | Horlicks Ltd | A tablet for use in treating peptic ulcers |
| GB906422A (en) * | 1958-05-02 | 1962-09-19 | Wellcome Found | Improvements in and relating to prolonged acting pharmaceutical preparations |
| US3015611A (en) * | 1959-08-25 | 1962-01-02 | Nysco Lab Inc | Low density whey-bound tablets |
| GB1063872A (en) * | 1962-08-11 | 1967-03-30 | Wellcome Found | Improvements in and relating to prolonged acting pharmaceutical compositions |
| US3594467A (en) * | 1968-10-09 | 1971-07-20 | Richardson Merrell Inc | Long-lasting troche |
| US3922379A (en) * | 1973-12-17 | 1975-11-25 | Abbott Lab | Microencapsulation process |
| US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| DE3250023T (en, 2012) * | 1981-01-14 | 1990-03-29 | ||
| FR2524312B1 (fr) * | 1982-04-01 | 1985-10-04 | Tech Cuir Centre | Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif |
| JPS59101423A (ja) * | 1982-12-02 | 1984-06-12 | Takada Seiyaku Kk | 新規なニフエジピン固形製剤 |
| CA1249968A (en) * | 1984-04-05 | 1989-02-14 | Kazuo Kigasawa | Ointment base |
| US4670251A (en) * | 1984-05-30 | 1987-06-02 | Igene Biotechnology, Inc. | Microcrystalline tableting excipient derived from whey |
| NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
| IL78017A (en) * | 1986-03-03 | 1989-06-30 | Yissum Res Dev Co | Sustained release tablets of theophylline |
| DE3702105A1 (de) * | 1987-01-24 | 1988-08-04 | Bayer Ag | Parenterale loesung |
| EP0326618A1 (en) * | 1987-03-04 | 1989-08-09 | Nippon Hypox Laboratories Incorporated | Medicinal composition containing albumin as carrier and process for its preparation |
| CA1324083C (en) * | 1987-03-09 | 1993-11-09 | Tetsu Miyoshi | Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
| DK179687D0 (da) * | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
| ES2054815T3 (es) * | 1987-09-08 | 1994-08-16 | Takeda Chemical Industries Ltd | Citoquinas insolubilizadas en agua. |
-
1989
- 1989-08-07 FR FR8910605A patent/FR2650502B1/fr not_active Expired - Fee Related
-
1990
- 1990-07-17 IL IL95105A patent/IL95105A0/xx unknown
- 1990-07-18 IE IE262990A patent/IE902629A1/en unknown
- 1990-07-19 IN IN578/MAS/90A patent/IN170789B/en unknown
- 1990-07-20 NZ NZ234593A patent/NZ234593A/en unknown
- 1990-07-20 DE DE4023136A patent/DE4023136A1/de not_active Withdrawn
- 1990-07-26 ZA ZA905886A patent/ZA905886B/xx unknown
- 1990-07-26 PT PT94823A patent/PT94823A/pt not_active Application Discontinuation
- 1990-08-01 LU LU87777A patent/LU87777A1/fr unknown
- 1990-08-01 CA CA002022447A patent/CA2022447A1/fr not_active Abandoned
- 1990-08-01 EP EP90402199A patent/EP0412877A1/fr not_active Withdrawn
- 1990-08-02 MA MA22193A patent/MA21923A1/fr unknown
- 1990-08-03 CS CS903838A patent/CS383890A3/cs unknown
- 1990-08-03 GB GB9017144A patent/GB2234898A/en not_active Withdrawn
- 1990-08-03 PE PE1990173269A patent/PE491A1/es unknown
- 1990-08-04 KR KR1019900011979A patent/KR910004181A/ko not_active Withdrawn
- 1990-08-06 FI FI903885A patent/FI903885A7/fi not_active Application Discontinuation
- 1990-08-06 JP JP2209061A patent/JPH0377819A/ja active Pending
- 1990-08-06 AU AU60239/90A patent/AU631235B2/en not_active Ceased
- 1990-08-06 CN CN90106874A patent/CN1049455A/zh active Pending
- 1990-08-06 HU HU904909A patent/HU204997B/hu not_active IP Right Cessation
- 1990-08-06 DD DD90343250A patent/DD297332A5/de not_active IP Right Cessation
- 1990-08-06 OA OA59830A patent/OA09301A/xx unknown
- 1990-08-06 NO NO90903442A patent/NO903442L/no unknown
- 1990-08-07 TN TNTNSN90111A patent/TNSN90111A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9017144D0 (en) | 1990-09-19 |
| PT94823A (pt) | 1991-04-18 |
| NZ234593A (en) | 1993-04-28 |
| CA2022447A1 (fr) | 1991-02-08 |
| HUT55230A (en) | 1991-05-28 |
| CS276556B6 (en) | 1992-06-17 |
| GB2234898A (en) | 1991-02-20 |
| JPH0377819A (ja) | 1991-04-03 |
| HU904909D0 (en) | 1991-01-28 |
| PE491A1 (es) | 1991-01-26 |
| HU204997B (en) | 1992-03-30 |
| KR910004181A (ko) | 1991-03-28 |
| OA09301A (fr) | 1992-09-15 |
| TNSN90111A1 (fr) | 1991-03-05 |
| IE902629A1 (en) | 1991-02-27 |
| IL95105A0 (en) | 1991-06-10 |
| IN170789B (en, 2012) | 1992-05-23 |
| DE4023136A1 (de) | 1991-02-14 |
| EP0412877A1 (fr) | 1991-02-13 |
| FR2650502A1 (fr) | 1991-02-08 |
| MA21923A1 (fr) | 1991-04-01 |
| DD297332A5 (de) | 1992-01-09 |
| NO903442D0 (no) | 1990-08-06 |
| CS383890A3 (en) | 1992-06-17 |
| NO903442L (no) | 1991-02-08 |
| AU6023990A (en) | 1991-02-07 |
| FR2650502B1 (fr) | 1994-05-27 |
| FI903885A7 (fi) | 1991-02-08 |
| CN1049455A (zh) | 1991-02-27 |
| AU631235B2 (en) | 1992-11-19 |
| FI903885A0 (fi) | 1990-08-06 |
| LU87777A1 (fr) | 1990-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1810A (en) | New pharmaceutical preparation for oral use | |
| GB8924823D0 (en) | Dosage inhalers | |
| AR244088A1 (es) | Metodo para la obtencion de una preparacion farmaceutica de liberacion sostenida. | |
| ZA96365B (en) | New oral pharmaceutical dosage form | |
| EP0428268A3 (en) | Pharmaceutical phenylpyridone derivatives | |
| FI914765A7 (fi) | Hidastetusti vapauttava oraalinen lääkeannosmuoto | |
| EP0381194A3 (en) | Drug preparation applicable to oral mucosa | |
| EP0408496A3 (en) | Solid dosage form for pharmaceutical substances | |
| ZA905861B (en) | Pharmaceutical composition for oral administration containing nac | |
| ZA902519B (en) | Pharmaceutical formulations | |
| GB8916682D0 (en) | Pharmaceutical compounds | |
| ZA905886B (en) | New oral pharmaceutical dosage form improving bioavailability | |
| ZA899948B (en) | Pharmaceutical preparation | |
| CS343490A3 (en) | Pharmaceutical | |
| EG19689A (en) | New pharmaceutical preparation for oral use | |
| ZA87111B (en) | Pharmaceutical dosage form | |
| IL93270A0 (en) | Pharmaceutical compositions for oral administration | |
| EG18240A (en) | New pharmaceutical preparation | |
| GB8921595D0 (en) | Pharmaceutical preparation | |
| HRP920590B1 (en) | New pharmaceutical preparation | |
| GB8906262D0 (en) | Pharmaceutical compounds | |
| GB8920738D0 (en) | Pharmaceutical compounds | |
| GB8911196D0 (en) | Pharmaceutical compounds | |
| GB8904040D0 (en) | Pharmaceutical compounds | |
| IE861995L (en) | Pharmaceutical dosage unit |